NCT00183911
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
- Locations
-
- U.S.C. / Norris Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Gastric Adenocarcinoma
Explore clinical trials studying Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.
191 public trials
60 recruiting studies
Gastric Adenocarcinoma trial results
NCT00464893
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
- Locations
-
- Innsbruck, Austria
- Hamburg, Berlin, Heidelberg, Köln, Halle, Germany
- Terrassa, Spain
- Nottingham, United Kingdom
NCT00411151
- Conditions
- Barrett Esophagus, Digestive System Diseases, Esophageal Diseases, +4 more
- Locations
-
- Universität Heidelberg, Nationales Zentrum für Tumorerkrankungen Heidelberg, Baden-Würtemberg, Germany
- Universitätsklinikum Tübingen Tübingen, Baden-Würtemberg, Germany
- TU München, Klinikum rechts der Isar, II. Med. Klinik und Poliklinik München, Bavaria, Germany
- Klinikum der Universität Würzburg Würzburg, Bavaria, Germany
NCT00352833
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
- Locations
-
- Hospital of Cologne-Merheim, Surgical Department Cologne, Germany
Completed
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
NCT00073502
- Conditions
- Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma
- Locations
-
- University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
- University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States
- Dept Internal Medicine Gastrointestinal Oncology Unit B-3000 Leuven, Belgium
Active, Not Recruiting
Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06914687
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +11 more
- Locations
-
- Fudan University Shanghai Cancer Hospital Shanghai, Shanghai Municipality, China
Active, Not Recruiting
Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
NCT05476796
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +12 more
- Locations
-
- Clinique de l'Europe Amiens, France
- Hopital Privé Arras Les Bonnettes Arras, France
- Institut Sainte Catherine Avignon, France
- Centre Hospitalier de Beauvais Beauvais, France
Active, Not Recruiting
Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management
NCT07522320
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
- Locations
-
- Unidade Local de Saúde do Alto Alentejo Portalegre, Portugal
Active, Not Recruiting
Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma
NCT04523818
- Conditions
- Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer
NCT05709574
- Conditions
- Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Arizona Cancer Center at UMC North/University Medical Center Tucson, Arizona, United States